Co-founder and Chief Business & Investment Officer
Rowan has over 30 years of experience working in innovative businesses applying computational methods to life science and patient data to understand disease and find new medicines and treatments for unmet medical needs. She is an experienced entrepreneur and advisor to fast growing companies and is a Co-founder and Chief Business and Investment Officer of PrecisionLife, expanding precision medicine in chronic disease.
She is also on the board of Digital Health and Care Wales a strategic health authority tasked with the digital transformation of NHS in Wales, and is responsible for oversight of the digital governance and safety committee.
Rowan holds a Masters in biochemistry from the University of Oxford and played a part in one of the university's first spinouts, Oxford Molecular Group, when it listed on the London Stock Exchange in 1994. She collaborated with the pioneering team at CERN to disseminate the applications to cloud computing frameworks in healthcare and pharmaceutical research.
